Clinical Trial Update: The Effects of Co-admin of Colesevelam and Sitagliptin on Glucose Metabolism in Subjects With Type 2 Diabetes Mellitus [NA]

View source ↗

Summary

A completed clinical trial assessed the combined use of colesevelam and sitagliptin in adults with type 2 diabetes and posted results in January 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Colesevelam (colesevelam)
• Sitagliptin (sitagliptin)

Snippet

Sponsor: KineMed | Conditions: Diabetes Mellitus, Type 2 | NA | Status: COMPLETED | Results posted: 2013-01-17